載入...

Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens

OBJECTIVE: To investigate relapse rates after the successful treatment of patients with non‐atypical endometrial hyperplasia who were randomised to either a levonorgestrel‐impregnated intrauterine system (LNG‐IUS; Mirena(®)) or two regimens of oral medroxyprogesterone acetate (MPA) after primary his...

全面介紹

Na minha lista:
書目詳細資料
發表在:BJOG
Main Authors: Ørbo, A, Arnes, M, Vereide, AB, Straume, B
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2015
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215722/
https://ncbi.nlm.nih.gov/pubmed/26630538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1471-0528.13763
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!